Sanakin therapy consists in application of serum with immune proteins (IL-1RA) directly to inflammation area.  Immune protein IL-1RA is natural receptor antagonist to interleukin-1 which causes cartilage damage, inflammation and pain.  The whole therapy consists of 3 up to 5 injections, which volume wise are individually consulted by physician subject to inflammation area and pain strength.

Main indications to apply this therapy are: degenerative joint changes, enthesopathy, and arthritis.